Evidence map›Paper›PMID 34969682›Full record

ArticleBMJ global health2021

Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia.

Rohan Arambepola, Yangyupei Yang, Kyle Hutchinson, Francis Dien Mwansa, Julie Ann Doherty, Frazer Bwalya, Phillimon Ndubani, Gloria Musukwa, William John Moss, Amy Wesolowski and 1 more

Abstract read
In one paragraph

Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rohan ArambepolaEpidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Yangyupei YangInternational Vaccine Access Center, International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-6011-4152
Kyle HutchinsonImplementation Science, Akros Zamba, Lusaka, Zambia.
Francis Dien MwansaDirectorate of Public Health and Research, Zambia Ministry of Health, Lusaka, Zambia.
Julie Ann DohertyImplementation Science, Akros Zamba, Lusaka, Zambia.
Frazer BwalyaImplementation Science, Akros Zamba, Lusaka, Zambia.
Phillimon NdubaniAdministration, Macha Research Trust, Choma, Zambia.
Gloria MusukwaChoma General Hospital, Zambia Ministry of Health, Lusaka, Zambia.
William John MossEpidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Amy WesolowskiEpidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Simon MutemboInternational Vaccine Access Center, International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA smutemb1@jhmi.edu.

Funding

Disease Emergence and Elimination: Using Mobility Data to Inform Spatial Disease DynamicsDP2LM013102 · NLM · JOHNS HOPKINS UNIVERSITY · PI WESOLOWSKI, AMY · 2018 to 2018
$2.5M
NLM NIH HHS DP2 LM013102
6 · The paper itself

Abstract

introductionDespite gains in global coverage of childhood vaccines, many children remain undervaccinated. Although mass vaccination campaigns are commonly conducted to reach these children their effectiveness is unclear. We evaluated the effectiveness of a mass vaccination campaign in reaching zero-dose children.

methodsWe conducted a prospective study in 10 health centre catchment areas in Southern province, Zambia in November 2020. About 2 months before a national mass measles and rubella vaccination campaign conducted by the Ministry of Health, we used aerial satellite maps to identify built structures. These structures were visited and diphtheria-tetanus-pertussis (DTP) and measles zero-dose children were identified (children who had not received any DTP or measles-containing vaccines, respectively). After the campaign, households where measles zero-dose children were previously identified were targeted for mop-up vaccination and to assess if these children were vaccinated during the campaign. A Bayesian geospatial model was used to identify factors associated with zero-dose status and measles zero-dose children being reached during the campaign. We also produced fine-scale zero-dose prevalence maps and identified optimal locations for additional vaccination sites.

resultsBefore the vaccination campaign, 17.3% of children under 9 months were DTP zero-dose and 4.3% of children 9-60 months were measles zero-dose. Of the 461 measles zero-dose children identified before the vaccination campaign, 338 (73.3%) were vaccinated during the campaign and 118 (25.6%) were reached by a targeted mop-up activity. The presence of other children in the household, younger age, greater travel time to health facilities and living between health facility catchment areas were associated with zero-dose status. Mapping zero-dose prevalence revealed substantial heterogeneity within and between catchment areas. Several potential locations were identified for additional vaccination sites.

conclusionFine-scale variation in zero-dose prevalence and the impact of accessibility to healthcare facilities on vaccination coverage were identified. Geospatial modelling can aid targeted vaccination activities.

Indexed as

MeaslesRubellaBayes TheoremChildHumansImmunization ProgramsProspective StudiesVaccinationZambiaepidemiologyimmunisationmathematical modellingmeasles

Identifiers

PMID34969682
PMCPMC8719156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.